ation. Pentostatin did not significantly increase chromosomal aberrations in V79 Chinese hamster lung cells exposed 3 hours to 1 to 3 mg/mL in the presence or absence of metabolic activation.
Impairment of Fertility: No fertility studies have been conducted in animals; however, in a 5-day intravenous toxicity study in dogs, mild seminiferous tubular degeneration was observed with doses of 1 and 4 mg/kg. The possible adverse effects on fertility in humans have not been determined.
Pregnancy
Pregnancy Category D: (See WARNINGS)
Nursing Mothers
It is not known whether NIPENT is excreted in human milk. Because many drugs are excreted in human milk, and because of the potential for serious adverse reactions in nursing infants from pentostatin, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of NIPENT to the mother.
Pediatric Use
Safety and effectiveness in children or adolescents have not been established.
ADVERSE REACTIONS
Most patients treated for hairy cell leukemia in the five NCI-sponsored Phase 2 studies and the Phase 3 SWOG study experienced an adverse event. The following table lists the most frequently occurring adverse events in patients treated with NIPENT (both frontline and IFN-refractory patients) compared with IFN (frontline only), regardless of drug association. The drug association of some adverse events is uncertain as they may be associated with the disease itself (eg, infection, hematologic suppression), but other events, such as the gastrointestinal symptoms, rashes, and abnormal liver function tests, can in many cases be attributed to the drug. Most adverse events that were assessed for severity were either mild or moderate, and diminished in frequency with continued therapy.
Percent of Patients
All Adverse Eventsa
Frontline,
Frontline,
IFN-Refractory,
Treated
Treated
Treated With
With NIPENT
With IFN
NIPENT
N=180
N=176
N=197
Nausea and/or Vomiting
63
22
53b
Fever
46
59
42
Rash
43
30
26
Fatigue
42
55
29
Leukopenia
22
15
60
Pruritus
21
6
10
Coughing/Increased Cough
20
15
17
Myalgia
19
36
11
Chills
19
34
11
Headache
17
29
13
Diarrhea
17
17
15
Abdominal Pain
16
15
4
Anorexia
13
10
16
Upper Respiratory Infection
13
8
16
Asthenia
12
13
10
Stomatitis
12
7
5
Rhinitis
11
15
10
Dyspnea
11
13
8
Anemia
8
5
35
Pain
8
19
20
Pharyngitis
8
11
10
Sweating/Increased Swe